金沢医科大学病院 腎臓内科学 科長/教授
日本内科学会 認定内科医・総合内科専門医・指導医 日本腎臓学会 腎臓専門医・腎臓指導医 日本透析医学会 透析専門医・透析指導医 日本アフェレシス学会 血漿交換療法専門医 日本リウマチ学会 リウマチ専門医・リウマチ指導医 日本臨床検査医学会 臨床検査専門医
続きを読む
日本内科学会 | 認定内科医・総合内科専門医・指導医 |
---|---|
日本腎臓学会 | 腎臓専門医・腎臓指導医 |
日本透析医学会 | 透析専門医・透析指導医 |
日本アフェレシス学会 | 血漿交換療法専門医 |
日本リウマチ学会 | リウマチ専門医・リウマチ指導医 |
日本臨床検査医学会 | 臨床検査専門医 |
金沢医科大学病院
1993年
金沢大学医学部医学科
卒業
1993年
金沢大学 第一内科
入局
2004年
NIH
留学
2006年
金沢大学医学部付属病院血液浄化療法部
助手(助教)
2007年
金沢大学医学部付属病院血液浄化療法部
部長,准教授
2019年
金沢医科大学
特任教授
2021年
金沢医科大学
科長/教授
Apheresis for Kidney Disease. Contrib Nephrol, 196: 188-193, 2018.
Furuichi, K, Wada, T
Clinico-pathological features of kidney disease in diabetic cases. Clin Exp Nephrol, 2018.
Furuichi, K, Shimizu, M, Okada, H, Narita, I, Wada, T
Diabetic Nephropathy: A Comparison of the Clinical and Pathological Features between the CKD Risk Classification and the Classification of Diabetic Nephropathy 2014 in Japan. Intern Med, 2018.
Furuichi, K, Shimizu, M, Hara, A, Toyama, T, Wada, T
Nationwide multicentre kidney biopsy study of Japanese patients with type 2 diabetes. Nephrol Dial Transplant, 2017.
Furuichi, K, Yuzawa, Y, Shimizu, M, Hara, A, Toyama, T, Kitamura, H, Suzuki, Y, Sato, H, Uesugi, N, Ubara, Y, Hisano, S, Ueda, Y, Nishi, S, Yokoyama, H, Nishino, T, Kohagura, K, Ogawa, D, Mise, K, Shibagaki, Y, Kimura, K, Haneda, M, Makino, H, Matsuo, S, Wada, T
Nationwide multicenter kidney biopsy study of Japanese patients with hypertensive nephrosclerosis. Clin Exp Nephrol, 2017.
Furuichi, K, Shimizu, M, Yuzawa, Y, Hara, A, Toyama, T, Kitamura, H, Suzuki, Y, Sato, H, Uesugi, N, Ubara, Y, Hoshino, J, Hisano, S, Ueda, Y, Nishi, S, Yokoyama, H, Nishino, T, Kohagura, K, Ogawa, D, Mise, K, Shibagaki, Y, Kimura, K, Haneda, M, Makino, H, Matsuo, S, Wada, T, Research Group of Diabetic, N, Nephrosclerosis, MoHL, Welfare of, J, Japan Agency for Medical, R, Development
Clinicopathological analysis of biopsy-proven diabetic nephropathy based on the Japanese classification of diabetic nephropathy. Clin Exp Nephrol, 2017.
Furuichi, K, Shimizu, M, Yuzawa, Y, Hara, A, Toyama, T, Kitamura, H, Suzuki, Y, Sato, H, Uesugi, N, Ubara, Y, Hohino, J, Hisano, S, Ueda, Y, Nishi, S, Yokoyama, H, Nishino, T, Kohagura, K, Ogawa, D, Mise, K, Shibagaki, Y, Makino, H, Matsuo, S, Wada, T, Research Group of Diabetic Nephropathy, MoHL, Welfare of, J, Japan Agency for Medical, R, Development
Japan Diabetic Nephropathy Cohort Study: study design, methods, and implementation. Clin Exp Nephrol, 17: 819-826, 2013.
Furuichi, K, Shimizu, M, Toyama, T, Koya, D, Koshino, Y, Abe, H, Mori, K, Satoh, H, Imanishi, M, Iwano, M, Yamauchi, H, Kusano, E, Fujimoto, S, Suzuki, Y, Okuda, S, Kitagawa, K, Iwata, Y, Kaneko, S, Nishi, S, Yokoyama, H, Ueda, Y, Haneda, M, Makino, H, Wada, T, Research Group of Diabetic Nephropathy, MoHL, Welfare of, J
Effects of adipose-derived mesenchymal cells on ischemia-reperfusion injury in kidney. Clin Exp Nephrol, 16: 679-689, 2012.
Furuichi, K, Shintani, H, Sakai, Y, Ochiya, T, Matsushima, K, Kaneko, S, Wada, T
Fas Ligand Has a Greater Impact than TNF-alpha on Apoptosis and Inflammation in Ischemic Acute Kidney Injury. Nephron Extra, 2: 27-38, 2012.
Furuichi, K, Kokubo, S, Hara, A, Imamura, R, Wang, Q, Kitajima, S, Toyama, T, Okumura, T, Matsushima, K, Suda, T, Mukaida, N, Kaneko, S, Wada, T
Matrix metalloproteinase-2 (MMP-2) and membrane-type 1 MMP (MT1-MMP) affect the remodeling of glomerulosclerosis in diabetic OLETF rats. Nephrol Dial Transplant, 26: 3124-3131, 2011.
Furuichi, K, Hisada, Y, Shimizu, M, Okumura, T, Kitagawa, K, Yoshimoto, K, Iwata, Y, Yokoyama, H, Kaneko, S, Wada, T
Chemokine/chemokine receptor-mediated inflammation regulates pathologic changes from acute kidney injury to chronic kidney disease. Clin Exp Nephrol, 13: 9-14, 2009.
Furuichi, K, Kaneko, S, Wada, T
IFN-inducible protein 10 (CXCL10) regulates tubular cell proliferation in renal ischemia-reperfusion injury. Nephron Exp Nephrol, 109: c29-38, 2008.
Furuichi, K, Wada, T, Kitajikma, S, Toyama, T, Okumura, T, Hara, A, Kawachi, H, Shimizu, F, Sugaya, T, Mukaida, N, Narumi, S, Matsushima, K, Kaneko, S
Roles of chemokines in renal ischemia/reperfusion injury. Front Biosci, 13: 4021-4028, 2008.
Furuichi, K, Wada, T, Kaneko, S, Murphy, PM
Chemokine receptor CCR1 regulates inflammatory cell infiltration after renal ischemia-reperfusion injury. J Immunol, 181: 8670-8676, 2008.
Furuichi, K, Gao, JL, Horuk, R, Wada, T, Kaneko, S, Murphy, PM
Interleukin-1-dependent sequential chemokine expression and inflammatory cell infiltration in ischemia-reperfusion injury. Crit Care Med, 34: 2447-2455, 2006.
Furuichi, K, Wada, T, Iwata, Y, Kokubo, S, Hara, A, Yamahana, J, Sugaya, T, Iwakura, Y, Matsushima, K, Asano, M, Yokoyama, H, Kaneko, S
Chemokine receptor CX3CR1 regulates renal interstitial fibrosis after ischemia-reperfusion injury. Am J Pathol, 169: 372-387, 2006.
Furuichi, K, Gao, JL, Murphy, PM
Gene therapy expressing amino-terminal truncated monocyte chemoattractant protein-1 prevents renal ischemia-reperfusion injury. J Am Soc Nephrol, 14: 1066-1071, 2003.
Furuichi, K, Wada, T, Iwata, Y, Kitagawa, K, Kobayashi, K, Hashimoto, H, Ishiwata, Y, Tomosugi, N, Mukaida, N, Matsushima, K, Egashira, K, Yokoyama, H
CCR2 signaling contributes to ischemia-reperfusion injury in kidney. J Am Soc Nephrol, 14: 2503-2515, 2003.
Furuichi, K, Wada, T, Iwata, Y, Kitagawa, K, Kobayashi, K, Hashimoto, H, Ishiwata, Y, Asano, M, Wang, H, Matsushima, K, Takeya, M, Kuziel, WA, Mukaida, N, Yokoyama, H
Role of Cytokines and Chemokines in Renal Ischemia-Reperfusion Injury. Drug News Perspect, 15: 477-482, 2002.
Furuichi, K, Wada, T, Yokoyama, H, Kobayashi, KI
Administration of FR167653, a new anti-inflammatory compound, prevents renal ischaemia/reperfusion injury in mice. Nephrol Dial Transplant, 17: 399-407, 2002.
Furuichi, K, Wada, T, Iwata, Y, Sakai, N, Yoshimoto, K, Kobayashi Ki, K, Mukaida, N, Matsushima, K, Yokoyama, H
Upregulation of fractalkine in human crescentic glomerulonephritis. Nephron, 87: 314-320, 2001.
Furuichi, K, Wada, T, Iwata, Y, Sakai, N, Yoshimoto, K, Shimizu, M, Kobayashi, K, Takasawa, K, Kida, H, Takeda, S, Matsushima, K, Yokoyama, H
Distinct expression of CCR1 and CCR5 in glomerular and interstitial lesions of human glomerular diseases. Am J Nephrol, 20: 291-299, 2000.
Furuichi, K, Wada, T, Sakai, N, Iwata, Y, Yoshimoto, K, Shimizu, M, Kobayashi, K, Takasawa, K, Kida, H, Takeda, SI, Mukaida, N, Matsushima, K, Yokoyama, H
Antimyeloperoxidase-antibody-positive rapidly progressive glomerulonephritis associated with Castleman's disease. Nephrol Dial Transplant, 13: 1556-1558, 1998.
Furuichi, K, Wada, T, Shimizu, M, Segawa, C, Ohta, S, Takasawa, K, Kobayashi, K, Yokoyama, H
今日の治療指針2019年版 腎疾患 糖尿病性腎症 執筆
今日の治療指針2018年版 腎疾患 膠原病による腎疾患 執筆
【受賞】日本腎臓学会 大島賞受賞
【対応可能言語】 日本語、英語
本ページにおける情報は、医師本人の申告に基づいて掲載しております。内容については弊社においても可能な限り配慮しておりますが、最新の情報については公開情報等をご確認いただき、またご自身でお問い合わせいただきますようお願いします。
なお、弊社はいかなる場合にも、掲載された情報の誤り、不正確等にもとづく損害に対して責任を負わないものとします。